Whether validating predictive biomarkers, designing a new companion diagnostic (CDx), or honing your study accrual and go-to-market strategies, we have the pharmaceutical development bioinformatics service offerings to set you on the path to success.
Having data that are consistent, reliable, and well understood is one of the biggest challenges facing pharmaceutical research and development.
To bring the power of precision medicine to more patients, pharmaceutical companies must overcome the barriers of finding, capturing, converting and organizing actionable data for improved decision making throughout the drug development process.
From research to regulatory submission, we help you connect data to insight for faster drug discovery, efficient trial design, and better patient outcomes.
Join us on Tuesday, June 9 at 11 AM ET for a live interactive webcast, where the QIAGEN Real-World Insights team will interview Dr. Anna Pokorska-Bocci, PhD, of Debiopharm International. The conversation will address the challenges of developing oncology targeted therapies and how Debiopharm was able to accelerate drug development with customized analyses and solutions from QIAGEN Real-World Insights. Register here.
Optimize your drug development strategy
Across the drug development lifecycle, our bioinformatics services provide customized support for your program—from the earliest stages of strategy and planning through FDA approval to commercialization.
Combining unparalleled data resources, with advanced analytics, industry-leading software, and scientific and regulatory expertise, our pharmaceutical development bioinformatics services deliver insight solutions matched for your specific needs.
Pharmaceutical Development Bioinformatics Services:
Life science and pharmaceutical companies create and consume vast amounts of complex data. We provide large-scale omics data analyses for diverse types of translational research, including pre-clinical and clinical studies (RNA-seq, Exome-seq, and targeted sequencing assays).
Leveraging proprietary software, expert-curated knowledgebases, and open-source tools, our team performs advanced bioinformatics to answer your scientific questions and generate meaningful insight.
The majority of cancer patients today are diagnosed and treated outside the context of clinical research—that is, in the real world.
QIAGEN’s Real-World Insights (RWI) is a professional and personalized service empowering pharmaceutical companies to better understand your target populations. Combining robust real-world data from over 200,000 cancer cases and advanced analytics, RWI helps you get drugs to market faster, expand their usage to new indications, and confidently answer critical questions.
Create and deliver bespoke drug development projects with a range of flexible options and services tailored to your unique requirements. Our specialized team works with you to develop the informatics tools and evidence resources you need to get consistent, reliable and actionable results through all phases of your study.
Looking for an experienced partner with a shared passion for innovation? QIAGEN Pharmaceutical Development Bioinformatics Services deliver valuable insights to support a successful clinical drug development plan with minimal time, effort and cost.
We work as an extension of your team, providing strategic consulting services to maximize the impact of your research, study and go-to-market plan.
Request a consultation with one of our pharmaceutical development bioinformatics specialists to discuss your specific research requirements.
Choose the best biomarkers and cancer indications for your molecularly targeted therapies
Expand beyond the one biomarker, one drug paradigm with expert molecular profiling and drug-response analyses
More easily find the right patients and quickly move to recruitment and regulatory acceptance